Poly (Lactic Acid) Nanoparticles: A Promising Hope to Overcome the Cancers

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 75

فایل این مقاله در 24 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JABS-11-2_003

تاریخ نمایه سازی: 31 تیر 1402

چکیده مقاله:

Nanoparticles are used mainly for the transmission of the therapeutic molecules (like drugs, proteins, or DNA) to the organ/tissue of human body. Polymeric nanoparticles are mostly applied for therapeutic effectiveness in cancer therapy. The micro environment of tumor tissues in vessels can assist nanoparticles in achieving their anticipated accumulation. Poly (lactic acid)(PLA) is a novel green polymer with natural sources (like sweet potato and sugar cane). PLA is a linear aliphatic which has great sustainability, renewability and compostability. PLA has popper mechanical, thermal and barrier properties. This biomaterial is thermoplastic polyester with biocompatibility, non-toxicity and biodegradability. Various forms of PLA nanoparticles are synthetized for biomedical applications like cancer treatments and wound healing process. This review article introduces the various structures of polylactic acid nanoparticles used to deliver anticancer drugs. Furthermore, the investigational approaches that are considered for using PLA nanoparticles in treatment of different types of cancers will be reported briefly.

نویسندگان

فرنازالسادات فتاحی

Department of Textile Engineering, Isfahan University of Technology, Isfahan, Iran

طاهره زمانی

The Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Calzoni E, Cesaretti A, Polchi A, Michele A-D, Tancini B, ...
  • Handali S, Moghimipour E, Rezaei M, Saremy S, Dorkoosh F-A. ...
  • Muniswamy V-J, Raval N, Gondaliya P, Tambe V, Kalia K, ...
  • Yuan JD, ZhuGe DL, Tong MQ, Lin MT, Xu XF, ...
  • Ghasemi R, Abdollahi M, Zadeh E-E, Khodabakhshi K, Badeli A, ...
  • Jin M, Jin G, Kang L, Chen L, Gao Z, ...
  • Kong N, Deng M, Sun X-N, Chen Y-D, Sui X-B. ...
  • Zhu YQ, Feijen J, Zhong ZY. Dual-targeted nanomedicines for enhanced ...
  • Peng Y, Nie J, Cheng W, Liu G, Zhu D, ...
  • Bolhassani A, Javanzad S, Saleh T, Hashemi M, Aghasadeghi M-R, ...
  • Sóti P-L, Weiser D, Vigh T, Nagy Z-K, Poppe L, ...
  • Teo P-Y, Cheng W, Hedrick J-L, Yang Y-Y. Co-delivery of ...
  • Xu G, Yu X, Zhang J, Sheng Y, Liu G, ...
  • Hu X, Liu S, Zhou G, Huang Y, Xie Z, ...
  • Barbara R, Belletti D, Pederzoli F, Masoni M, Keller J, ...
  • Hu D, Chen L, Qu Y, Peng J, Chu B, ...
  • Ahmad N, Ahmad R, Alam M-A, Ahmad F-J. Enhancement of ...
  • Andima M, Costabile G, Isert L, Ndakala A-J, Derese S, ...
  • Donida B, Tauffner B, Raabe M, Immich M-F, de Farias ...
  • Zhang L, Zhu H, Gu Y, XiaohuaWang, Wu P. Dual ...
  • Srivastava R-M, Singh S, Dubey S-K, Misra K, Khar A. ...
  • Nguyen T-T-T, Ghosh C, Hwang S-G, Tran L-D, Park J-S. ...
  • Meel R, Lammers T, Hennink W-E. Cancer nanomedicines: oversold or ...
  • Jaffary F, Nilforoushzadeh M-A, Sharifian H, Mollabashi Z. Wound healing ...
  • Li W, Tan X, Luo T, Shi Y, Yang Y, ...
  • Sun L, Wang L, Cun D, Tong H, Yan R, ...
  • Kuo Y-C, Tsai H-C. Rosmarinic acid- and curcumin-loaded polyacrylamide-cardiolipin-poly(lactide-coglycolide) nanoparticles ...
  • Sanjay K, Anchal S, Uma N, Sweta M, Pratibha K. ...
  • Norouzi M, Nazari B, Miller D-W. Electrospun-based systems in cancer ...
  • Huang N, Lu S, Liu X-G, Zhu J, Wang Y-J, ...
  • Narayanan S, Binulal N-S, Mony U, Manzoor K, Nair S, ...
  • Wang H, Agarwal P, Zhao S, Xu R-X, Yu J, ...
  • Yang X-Z, Dou S, Sun T-M, Mao C-Q, Wang H-X, ...
  • Singh N-A, Mandal A-K-A, Khan Z-A. Fabrication of PLA-PEG Nanoparticles ...
  • Jahan S-T, Sams M-A-S, Walliser M, Haddadi A. Targeted Therapeutic ...
  • Koda S, Okumura N, Kitano J, Koizumi N, Tabata Y. ...
  • Casasola R, Thomas N-L, Georgiadou S. Electrospinning of poly(lactic acid): ...
  • Doustgani A. Doxorubicin release from optimized electrospun polylactic acid nanofibers. ...
  • Doustgani A, Ahmadi E. Melt electrospinning process optimization of polylactic ...
  • Fasehee H, Dinarvand R, Ghavamzadeh A, Esfandyari-Manesh M, Moradian H, ...
  • Rezaei F, Nikiforov A, Morent R, De Geyter N. Plasma ...
  • Tautzenberger A, Kovtun A, Ignatius A. Nanoparticles and their potential ...
  • Liu Y, Zhao G, Xu C-F, Luo Y-L, Lu Z-D, ...
  • Mao Z, Li J, Huang W, Jiang H, Zimba B-L, ...
  • Zhang Z, Feng S-S. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer ...
  • Gorrasi G, Sorrentino A, Pantani R. Modulation of Biodegradation Rate ...
  • Chereddy K-K, Coco R, Patrick B. Memvanga, Bernard Ucakar, Anne ...
  • Oliveira J-E, Moraes E-A, Marconcini J-M, C. Mattoso L-H, Glenn ...
  • Mucha M, Bialas S, Kaczmarek H. Effect of nanosilver on ...
  • Rodríguez-Tobías H, Morales G, Ledezma A, Romero J, Grande D. ...
  • Retulainen E, Immonen K, Wikström L, Anttila U, Virtanen S. ...
  • Lu F, Yu H, Yan C, Yao J. Polylactic acid ...
  • Birhanu G, Tanha S. Dexamethasone loaded multi-layer poly-l-lactic acid/pluronic P۱۲۳ ...
  • Iwatake A, Nogi M, Yano H. Cellulose nanofiber-reinforced polylactic acid. ...
  • Fattahi F-S, Khoddami A, Avinc O. Poly(lactic acid) (PLA) Nanofibers ...
  • Fattahi F-S, Khoddami A, Izadian H. Review on Production, Properties, ...
  • Fattahi F-S, Khoddami A, Izadan H. A Review on Poly(lactic ...
  • Fattahi F, Izadan H, Khoddami A. Investigation into the Effect ...
  • Fattahi F, Izadan H, Khoddami A. Deep Dyeing of Poly ...
  • Fu Y, Liu L, Cheng R, Cui W. ECM Decorated ...
  • Huang Y, Wang T, Zhao X, Wang X, Zhou L, ...
  • Mai F, Habibi Y, Raquez J-M, Dubois P, Feller J-F, ...
  • Khoo R-Z, Ismail H, Chow W-S. Thermal and Morphological Properties ...
  • Palanikumar L, Al-Hosani S, Kalmouni M, Nguyen V-P, Ali L, ...
  • Haggag Y-A, Ibrahim R-R, Hafiz A-A. Design, Formulation and in ...
  • Ibrahim W-N, Muizzuddin L, Doolaanea A-A. Formulation, Cellular Uptake and ...
  • Amani A, Kabiri T, Shafiee S, Hamidi A. Preparation and ...
  • Kong N, Deng M, Sun X-N, Chen Y-D, Sui X-B. ...
  • Emre k. The biochemical content and antioxidant capacities of endemic ...
  • Hoang N-H, Lim C. Characterization of a triblock copolymer, poly(ethylene ...
  • Massadeh S, Alaamery M, Al-Qatanani S, Alarifi S, Bawazeer S, ...
  • Dou S, Yang X-Z, Xiong M-H, Sun C-Y, Yao Y-D, ...
  • Singh K-B, Hahm E-R, Kim S-H, Wendell S-G, Singh S-V. ...
  • Prabha S, Labhasetwar V. Critical Determinants in PLGA/PLA Nanoparticle-Mediated Gene ...
  • Zhao M, van Straten D, Broekman M-L-D, Préat V, Schiffelers ...
  • Ganipineni L-P, Danhier F, Préat V. Drug delivery challenges and ...
  • Ran D, Zhou J, Chai Z, Li J, Xie C, ...
  • Jain D, Bajaj A, Athawale R, Shrikhande S, Goel P-N, ...
  • Hu Q, Gu G, Liu Z, Jiang M, Kang T, ...
  • Madani F, Esnaashari S-S, Bergonzi M-C, Webster T-J, Younes H-M, ...
  • Milne K, Sturrock B, Chevassut T. Chronic Lymphocytic Leukaemia in ...
  • Fan L, Liu C, Hu A, Liang J, Li F, ...
  • Medikonda R, Dunn G, Rahman M, Fecci P, Lim M. ...
  • Festuccia C, Biordi AL, Tombolini V, Hara A, Bailey D. ...
  • Liu E-K, Sulman E-P, Wen P-Y, Kurz S-C. Novel Therapies ...
  • Pieper S, Onafuye H, Mulac D, Cinatl J, Wass M-N, ...
  • Pistollato F, Bremer-Hoffmann S, Basso G, Cano S-S, Elio I, ...
  • Wang R, Dang M, Harada K, Han G, Wang F, ...
  • Zhang Z, Feng S-S. The drug encapsulation efficiency, in vitro ...
  • Kole C, Charalampakis N, Tsakatikas S, Vailas M, Moris D, ...
  • Khaledian M, Nourbakhsh M-S, Saber R, Hashemzadeh H, Darvishi MH. ...
  • Wu P, Zhou Q, Zhu H, Zhuang Y, Bao J. ...
  • Wu P, Zhu H, Zhuang Y, Sun X, Gu N. ...
  • Ding R, Zhang H. Effects of Magnetic Nanoparticle Drug Delivery ...
  • Xiang H, Mu Y, Hu C, Luo X. Biocompatibility and ...
  • Zhu D, Tao W, Zhang H, Liu G, Wang T, ...
  • Shim M-K, Na J, Cho I-K, Jang E-H, Park J, ...
  • Etman S-M, Mehanna R-A, Bary A-A, Elnaggar Y-S-R, Abdallah O-Y. ...
  • Huang X, Ding L, Liu X, Tong R, Ding J, ...
  • Tempero M, Oh D-Y, Tabernero J, Reni M, Van Cutsem ...
  • Jaidev L-R, Krishnan U-M, Sethuraman S. Gemcitabine loaded biodegradable PLGA ...
  • Yang C, Hu T, Cao H, Zhang L, Zhou P, ...
  • Mullen M, Karakasis K, Rottapel R, Oza A-M. Advances in ...
  • Yao S, Li L, Su X-t, Wang K, Lu Z-j, ...
  • Wang Y, Liu P, Duan Y, Yin X, Wang Q, ...
  • Mineo P-G, Foti C, Vento F, Montesi M, Panseri S, ...
  • Yu A-M, Choi Y-H, Tu M-J. RNA Drugs and RNA ...
  • Chen Q. Chapter Seven - Recombinant Therapeutic Molecules Produced in ...
  • Kumar A, Nisha C-M, Silakari C, Sharma I, Anusha K, ...
  • Sehgal S-A, Hammad M-A, Tahir R-A, Akram H-N, Ahmad F. ...
  • Fortuni B, Inose T, Ricci M, Fujita Y, Van Zundert ...
  • Dang Y, Guan J. Nanoparticle-based drug delivery systems for cancer ...
  • Mitchell M-J, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, ...
  • Kamaly N, Yameen B, Wu J, Farokhzad O-C. Degradable Controlled-Release ...
  • Jain A-K, Thareja S. In vitro and in vivo characterization ...
  • Jia L, Wang R, Fan Y. Encapsulation and release of ...
  • Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: Drug ...
  • De Jong WH, Borm PJA. Drug delivery and nanoparticles:applications and ...
  • Patra J-K, Das G, Fraceto L-F, Campos E-V-R, Rodriguez-Torres M- ...
  • Lombardo D, Kiselev M-A, Caccamo M-T. Smart Nanoparticles for Drug ...
  • D’Souza S. A Review of In Vitro Drug Release Test ...
  • Cheng Z, Zhang Z, Han Y, Wang J, Wang Y, ...
  • Przystupski D, Michel O, Rossowska J, Kwiatkowski S, Saczko J, ...
  • Dariva C-G, Figueiredo J-P-H, Ferreira C, Laranjo M, Botelho M-F, ...
  • Kumar K-S, Selvaraj V, Alagar M. Synthesis of PET-PLA/Drug Nanoparticles ...
  • Sim T, Kim J-E, Hoang N-H, Kang J-K, Lim C, ...
  • Danafar H. Study of the Composition of Polycaprolactone/Poly (Ethylene Glycol)/Polycaprolactone ...
  • نمایش کامل مراجع